Quarterly report pursuant to Section 13 or 15(d)

Equity Transactions - Schedule of Stock Option Activity (Details)

v3.19.3
Equity Transactions - Schedule of Stock Option Activity (Details)
9 Months Ended
Sep. 30, 2019
USD ($)
$ / shares
shares
Share-based Payment Arrangement [Abstract]  
Number of options outstanding beginning balance | shares 2,478,974
Number of options granted | shares 735,667
Number of options forfeited | shares (300,000)
Number of options outstanding ending balance | shares 2,914,641
Number of options vested | shares 1,710,067
Number of options exercisable | shares 1,147,863
Weighted average exercise price outstanding beginning balance $ 5.25
Weighted average exercise price granted 3.97
Weighted average exercise price forfeited 5.05
Weighted average exercise price exercised
Weighted average exercise price outstanding ending balance 5.05
Weighted average exercise price vested 4.46
Weighted average exercise price exercisable $ 5.20
Weighted average remaining contractual term outstanding 2 years 11 months 4 days
Weighted average remaining contractual term outstanding 2 years 6 months 3 days
Aggregate intrinsic value outstanding beginning balance | $ $ 2,660,000
Aggregate intrinsic value granted
Aggregate intrinsic value forfeited
Aggregate intrinsic value exercised | $
Aggregate intrinsic value outstanding ending balance | $
Aggregate intrinsic value vested | $
Aggregate intrinsic value exercisable | $